Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Epidemiol Infect ; 140(4): 689-96, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21676354

RESUMEN

This study investigated individual and contextual factors associated with the duration of diarrhoeal episodes in 693 young children living in a large Brazilian city who were followed-up for at least 3 months. The outcome is analysed as a continuous variable, by means of a hierarchical conceptual model organizing the factors in meaningful blocks. A total of 2397 episodes were recorded (median duration 2 days, interquartile range 1-3 days). Low percentage of households connected to the sewerage system in the neighbourhood, low family purchasing power, high agglomeration, mother aged <19 years, low zinc content in child's diet, and episode severity were significantly associated with longer duration (0·26-0·69 days more). Purchasing power effect was largely mediated by environmental conditions, characteristics of the child, and hygienic behaviour. Environmental conditions acted as a possible effect modifier, enhancing the effect on duration of diarrhoea of the child not having being vaccinated against measles or breastfed for >6 months.


Asunto(s)
Diarrea/epidemiología , Factores de Edad , Brasil/epidemiología , Preescolar , Dieta , Composición Familiar , Femenino , Humanos , Incidencia , Lactante , Estudios Longitudinales , Masculino , Análisis Multivariante , Factores Socioeconómicos , Factores de Tiempo , Población Urbana/estadística & datos numéricos
2.
Int J Tuberc Lung Dis ; 9(10): 1171-3, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16229231

RESUMEN

Bacille Calmette-Guérin (BCG) efficacy against pulmonary disease is highly variable; until very recently there was no evidence of protection after 10 years. In the control arm of a trial of efficacy of revaccination of schoolchildren in Brazil we found substantial protection (39%; 95%CI 9-58) of neonatal BCG against all forms of tuberculosis (TB) 15-20 years after vaccination, much longer than previously believed. This confirms recent findings from an earlier trial, and must be considered in the design of trials of new TB vaccines and in policy decisions based on assumed lack of neonatal BCG protection with time.


Asunto(s)
Vacuna BCG/administración & dosificación , Tuberculosis Pulmonar/prevención & control , Adolescente , Brasil/epidemiología , Niño , Humanos , Recién Nacido , Factores de Tiempo , Tuberculosis Pulmonar/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA